Please ensure Javascript is enabled for purposes of website accessibility

Paragon acquisition gives a jolt to Md. biotech industry (access required)

Ten years ago, Paragon Bioservices moved into the University of Maryland BioPark with just 30 employees and a change of direction to focus on manufacturing gene therapies. Monday the firm announced that it had agreed to be acquired by Catalent Biologics in a more than $1.2 billion deal expected to be completed this quarter. It has ...

To purchase a reprint of this article, contact [email protected].